Add Row
Add Element
cropper
update
Pulse On Wellcare
update
Add Element
  • Home
  • Categories
    • Healthcare
    • Trends
    • Insights
    • Southwest
    • Strategies
    • Prevention
    • Lifestyle
    • Mental Health
    • Preventative Care
    • Nutrition & Meal Planning
    • Telemedicine Access
    • Workplace Wellness
    • Wellness Tips
  • Events
  • Healthy Aging
October 23.2025
2 Minutes Read

Mizoram Faces Growing TB Crisis With 121 Deaths in 2025

Mortuary scene with feet and toe tag, Mizoram TB deaths.

Understanding the Rising TB Crisis in Mizoram

Mizoram is facing a grave health challenge with over 121 reported deaths from multidrug-resistant tuberculosis (MDR-TB) since the start of the year. The state's health department emphasizes the urgency of this public health crisis, detailing that nearly 1,870 people have been diagnosed with TB between January 1 and October 10, 2025. Alarmingly, the number of victims continues to rise, marking a worrying trend in a region that has struggled to combat this disease.

Statistics That Tell a Story

Comparing current data to previous years highlights a steep increase in fatalities due to TB. For instance, in 2020, only 31 lives were lost to the disease. By 2024, this figure had emerged to 148, emphasizing the escalating health crisis within Mizoram. According to the health officials, children and adolescents are particularly affected, with nearly 1,761 cases reported in individuals aged 14 or younger. This demographic vulnerability calls for immediate public health interventions and community engagement to tackle these startling statistics.

The Role of Community Engagement in Fighting TB

The government's strategies, including the Pradhan Mantri TB Mukt Bharat Abhiyan launched in September 2022, are especially focused on community involvement in eradication efforts. Facilitating donations and support for TB patients through the “Nikshay” online platform, the initiative encourages locals to contribute towards a TB-free Mizoram. More than 100 people have registered to assist those fighting TB through this platform, showcasing an inspiring community response to a national health crisis.

The Need for Telemedicine Access

One innovative approach to combat the increasing TB cases is the integration of telemedicine into healthcare strategies. With geographical challenges in many regions, including Mizoram, telemedicine offers better access to diagnostic testing and follow-up care. This could be particularly beneficial for vulnerable populations, ensuring that individuals can receive timely treatment without the barriers of travel or resource availability.

Lessons From History: TB Control Efforts and Progress

Looking at the broader landscape, the fight against TB has evolved. The World Health Organization (WHO) set ambitious targets to eradicate TB globally by 2030, but India has committed to achieving a TB-free status five years earlier. With initiatives like the Active Case Finding campaign and the establishment of TB-free villages, Mizoram has shown potential for progress as seen in 2024 when 122 villages were declared TB-free. Yet, this must be coupled with sustained effort and awareness raising.

Moving Forward: What Can We Do?

The increase in TB cases in Mizoram presents unique challenges, but it also offers the opportunity for a unified community response. As residents and health officials focus on prevention and treatment, harnessing local resources, strengthening healthcare access, and fostering community participation remains essential. Advocating for health equity, especially among the most affected, is key as Mizoram seeks solutions to a growing public health threat.

To become an active part of the solution, consider supporting local health initiatives or the TB-free campaign in your area. Your involvement can make a difference in combating this critical health challenge in Mizoram.

Telemedicine Access

24 Views

0 Comments

Write A Comment

*
*
Please complete the captcha to submit your comment.
Related Posts All Posts
04.06.2026

Dark Revelations: How Telegram Facilitated Kanpur’s Kidney Trafficking Racket

Update Dark Revelations of Kanpur's Kidney Trafficking RacketThe recent exposure of a kidney trafficking racket in Kanpur has alarmed health authorities and citizens alike. At the heart of this illicit scheme is a network of medical professionals and middlemen exploiting vulnerable individuals in need of financial assistance. Medical officers reported that kidneys were allegedly acquired at a price of around ₹10 lakh (approximately $13,000) and then sold to needy patients—many of whom were from foreign countries—for as much as ₹60 lakh (around $76,000). What came as a shock was that the whole operation was uncovered following a conflict over a mere ₹50,000.The Role of Technology: Telegram’s Dark SideAccording to investigations, modern technology has played a pivotal role in facilitating these unlawful transactions. Encrypted messaging services such as Telegram were used by traffickers to promote illicit organ sales discreetly. The use of such platforms allowed those involved to maintain anonymity while luring financially desperate individuals into a perilous arrangement.The Inciting Incident: A Student's Call for HelpThe windfall began with Ayush, an MBA student from Bihar, who initially hoped to turn a financial corner by selling one of his kidneys for ₹10 lakh. Yet, after only receiving ₹9.5 lakh, Ayush felt cheated and reported the matter to the police. Alarmingly, his story is not unique; it exposes how reduced economic opportunities lead individuals to desperate measures, making them easy targets for exploitative traffickers.A Network of Illegal OperationsSubsequent investigations revealed that this kidney racket transcended Kanpur, impacting nearby cities and potentially even reaching international borders to locations like Nepal. Over a dozen illegal transplants have been linked to this network, giving rise to serious concerns about public health and safety in volatile medical practices.Regulatory Actions and Awareness InitiativesIn light of these revelations, local health authorities are triggered to act. Facilities implicated in these operations have begun to face scrutiny and may have their hospital licenses revoked. Regulatory officials emphasize the need for stricter oversight and regulations surrounding organ transplants to prevent future occurrences of such inhumane practices.What You Can Do: Stay InformedThe exposure of this kidney racket calls for community awareness and vigilance. It’s crucial for individuals to be educated about the risks associated with both buying and selling organs illegally. Discussions about organ donation, ethical practices, and alternative solutions for those in financial need can catalyze change.

04.05.2026

Exploring Drug Advertisement Proposals: Why Chemists Say No

Update Understanding the Opposition to New Drug Proposals The All India Organisation of Chemists and Druggists (AIOCD) has voiced strong opposition to several proposals put forth by the Drug Technical Advisory Board (DTAB) regarding drug advertisements and the sale of nicotine gum. Their concerns reflect a dedication to public health and a commitment to maintaining ethical practices within the pharmaceutical industry. Public Health and Safety at Stake The AIOCD presented its arguments during the 93rd DTAB meeting held on February 16, 2026. There is a significant emphasis on public health, with the AIOCD warning that allowing advertisements for prescription-only medicines could lead to self-medication and misuse. Notably, concerns surrounding nicotine gum also highlight the addictive nature of nicotine, emphasizing a need for regulatory caution. The potential for unregulated sales via e-pharmacies further complicates the landscape, suggesting that patient safety could be jeopardized without stringent oversight. The Risks of E-Pharmacy In their submission, the AIOCD condemned the increasing prevalence of illegal e-pharmacies, positing that they pose considerable risks to public health. E-pharmacies, which often operate without valid licenses as per the Drugs and Cosmetics Act, not only threaten the integrity of traditional licensed chemists but also create an environment conducive to unsafe drug distribution. The AIOCD emphasized that public health should always be the paramount consideration, advocating for regulatory clarity to curb this issue. A Call for Regulated Trade Amid the concerns, the AIOCD is supportive of implementing Good Distribution Practices (GDP) to strengthen the drug distribution system and ensure medicines meet safety standards. While endorsing structured guidelines, the organization insists on a phased implementation to alleviate the compliance burden on smaller enterprises, thereby ensuring equitable practices across the industry. What This Means for Consumers For consumers, these discussions translate into a desire for safety, quality, and assurance that the medicines they use are not only effective but also prescribed responsibly. The push against the commercialization of drugs underscores the necessity for informed usage rather than excitement over advertisements. Looking to the Future: What’s Next? As this dialogue unfolds, the implications for policies surrounding telemedicine and the integration of technology in healthcare continue to evolve. Addressing the legality and regulation of telemedicine practices could become crucial as they intersect with prescription medicine distribution. Ultimately, any changes made must prioritize patient health and ethical standards within the pharmaceutical industry.

04.04.2026

GLP-1 Receptor Agonists: The New Frontier in Youth Diabetes Care

Update The Rising Trend of GLP-1 Receptor Agonists in Young Patients The medical landscape for treating type 2 diabetes (T2D) in youths is shifting significantly, with glucagon-like peptide-1 (GLP-1) receptor agonists leading the way. A recent study showcases the increasing prescription rates of these innovative medications among children and adolescents. This trend signals a critical evolution in diabetes management, reflecting not only the growing prevalence of the disease but also advancements in therapeutic options. Understanding GLP-1 Receptor Agonists: A New Hope GLP-1 receptor agonists, including popular options like Ozempic (semaglutide), provide multifaceted benefits for young patients struggling with obesity and diabetes. These medications act by enhancing insulin secretion, inhibiting glucagon release for better blood sugar control, and promoting weight loss by reducing appetite. The recent meta-analysis discussing their effectiveness indicates a decrease in hemoglobin A1c levels and moderate weight loss, making them appealing alternatives to traditional treatments like metformin. Nonetheless, concerns regarding gastrointestinal side effects and long-term safety remain paramount and must be addressed by healthcare providers. Making Sense of These Promising Outcomes As reported in various studies, the efficacy of GLP-1 receptor agonists shows promise yet comes with nuances. The most notable findings include an average weight loss of around 3 kg and a reduction in body mass index (BMI) among pediatric patients, alongside a noted decrease in A1c levels by approximately 0.44%. While these numbers are encouraging, practitioners must weigh them against potential risks including gastrointestinal issues and psychological effects like increased depression and suicidality risk. The balance between benefits and risks is crucial, particularly in younger patients. Access and Ethical Considerations: A Community Challenge Access to GLP-1 receptor agonists introduces another layer of complexity. These medications, while effective, are often costly and not universally covered by insurance. This poses a challenge for families trying to secure the best care for their children. Ethically, healthcare providers must navigate the tightrope between advocating for these treatments and addressing the disparities in availability. Public awareness and advocacy can play significant roles in ensuring fair access. GLP-1 Receptor Agonists: A Community Perspective The conversations around these medications highlight not just a medical issue but a community-driven endeavor. Families, educators, and healthcare professionals are crucial in creating an environment that fosters understanding and support for youths managing diabetes. Chaired meetings in local communities can help raise awareness about diabetes management and the importance of supportive resources, including telemedicine that increases access to specialists. Final Thoughts: Empowering Families Through Knowledge As we witness the rising use of GLP-1 receptor agonists in managing pediatric type 2 diabetes, it becomes increasingly essential to provide families with adequate information and support. By understanding the benefits and considerations associated with these medications, caregivers can empower their children to lead healthier lives. Together, through ongoing dialogue and educational efforts, we can cultivate a supportive community that champions youth health.

Terms of Service

Privacy Policy

Core Modal Title

Sorry, no results found

You Might Find These Articles Interesting

T
Please Check Your Email
We Will Be Following Up Shortly
*
*
*